The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer

AIM: Chemotherapy results in permanent loss of ovarian function in some premenopausal women. Accurate identification in women with hormone-sensitive early breast cancer (eBC) would allow optimisation of subsequent endocrine treatment. We sought to assess whether analysis of anti-Müllerian hormone (A...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, R.A., Mansi, J., Coleman, R.E., Adamson, D.J.A., Leonard, R.C.F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ltd 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733385/
https://www.ncbi.nlm.nih.gov/pubmed/29117576
http://dx.doi.org/10.1016/j.ejca.2017.10.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733385/
https://www.ncbi.nlm.nih.gov/pubmed/29117576
http://dx.doi.org/10.1016/j.ejca.2017.10.001

Ejemplares similares